These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 13893910)
21. Sublingual immunotherapy efficacy of Dermatophagoides farinae vaccine in a murine asthma model. Yu HQ; Li XH; Guo H; Liu ZG; Ran PX; Ji KM; Wang J Int Arch Allergy Immunol; 2010; 152(1):41-8. PubMed ID: 19940504 [TBL] [Abstract][Full Text] [Related]
22. [The role of immunotherapy in the prevention of allergic diseases]. Lugović-Mihić L; Duvancić T Acta Med Croatica; 2011; 65(2):195-201. PubMed ID: 22359887 [TBL] [Abstract][Full Text] [Related]
23. American Academy of Allergy, Asthma & Immunology--2008 Annual Meeting. Bielory L IDrugs; 2008 May; 11(5):309-11. PubMed ID: 18465665 [No Abstract] [Full Text] [Related]
24. Allergy and desensitization; cure of bronchial asthma with a bacterial vaccine. PANT KC; SINHA KC Ind Med Gaz; 1949 Dec; 83(12):556. PubMed ID: 18125632 [No Abstract] [Full Text] [Related]
25. [Effect of desensitization with a bacterial vaccine on the clinical course and delayed skin responses as well as serum properdin level in children with infectious-allergic asthma]. Pyda E; Pinkawa E Pol Tyg Lek; 1977 Oct; 32(44):1711-3. PubMed ID: 917916 [No Abstract] [Full Text] [Related]
26. ALLERGIC TRACHEITIS; A PROBLEM IN PEDIATRIC ALLERGY. LEVIN SJ; SCHERER RA Ann Allergy; 1964 Jan; 22():26-32. PubMed ID: 14106927 [No Abstract] [Full Text] [Related]
27. [CONDUCT OF ALLERGIC TREATMENTS IN AN ALTITUDE CLIMATE]. ENAUD-BRULEY E; ENAUD B Clinique (Paris); 1963 Sep; 58():499-501. PubMed ID: 14089605 [No Abstract] [Full Text] [Related]
28. Editorial overview: novel concepts in the pathogenesis and therapy of allergy and asthma. Umetsu DT; DeKruyff RH Springer Semin Immunopathol; 2004 Feb; 25(3-4):231-6. PubMed ID: 15007628 [No Abstract] [Full Text] [Related]
30. [Immunotherapy as the prevention of asthma and allergy]. Rogala B Pol Merkur Lekarski; 2004 May; 16 Suppl 1():40-1. PubMed ID: 15524013 [TBL] [Abstract][Full Text] [Related]
31. [Clinical efficacy and costs of the three-year specific allergen immunotherapy--retrospective study]. Targowski T; Jahnz-Rózyk K; Przekora P; Kucharczyk A; Owczarek W Pol Merkur Lekarski; 2011 Aug; 31(182):106-10. PubMed ID: 21936348 [TBL] [Abstract][Full Text] [Related]
32. GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Zuberbier T; Bachert C; Bousquet PJ; Passalacqua G; Walter Canonica G; Merk H; Worm M; Wahn U; Bousquet J Allergy; 2010 Dec; 65(12):1525-30. PubMed ID: 21039596 [TBL] [Abstract][Full Text] [Related]
33. [Test results and desensitization results in allergic diseases in bakers. (Rhinitis, asthma and eczema in bakers)]. Wüthrich B Praxis; 1968 Sep; 57(38):1294-303. PubMed ID: 4239694 [No Abstract] [Full Text] [Related]
34. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases]. Malling HJ Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284 [TBL] [Abstract][Full Text] [Related]
35. The safety and efficiency of immunotherapy. Alvarez-Cuesta E; Hernández Peña J J Investig Allergol Clin Immunol; 1997; 7(5):358-9. PubMed ID: 9416546 [No Abstract] [Full Text] [Related]